P
Peter J. Barnes
Researcher at National Institutes of Health
Publications - 1554
Citations - 177909
Peter J. Barnes is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Asthma & COPD. The author has an hindex of 194, co-authored 1530 publications receiving 166618 citations. Previous affiliations of Peter J. Barnes include University of Nebraska Medical Center & Novartis.
Papers
More filters
Journal ArticleDOI
How corticosteroids control inflammation: Quintiles Prize Lecture 2005.
TL;DR: In patients with COPD and severe asthma and in asthmatic patients who smoke HDAC2 is markedly reduced in activity and expression as a result of oxidative/nitrative stress so that inflammation becomes resistant to the anti‐inflammatory actions of corticosteroids, and theophylline, by activating HDAC, may reverse this cortiosteroid resistance.
Journal ArticleDOI
Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force.
Journal ArticleDOI
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Claus Vogelmeier,Gerard J. Criner,Fernando J. Martinez,Antonio Anzueto,Peter J. Barnes,Jean Bourbeau,Bartolome R. Celli,Rongchang Chen,Marc Decramer,Leonardo M. Fabbri,Peter Frith,David M.G. Halpin,M. Victorina López Varela,Masaharu Nishimura,Nicolas Roche,Roberto Rodriguez-Roisin,Don D. Sin,Dave Singh,Robert Stockley,Jørgen Vestbo,Jadwiga A. Wedzicha,Alvar Agusti +21 more
TL;DR: The assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation, and the concept of de‐escalation of therapy is introduced in the treatment assessment scheme.
Journal ArticleDOI
Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial.
Paul M. O'Byrne,Peter J. Barnes,Roberto Rodriguez-Roisin,Eva Runnerstrom,Thomas Sandström,Klas Svensson,Anne E. Tattersfield +6 more
TL;DR: Low dose inhaled budesonide alone reduced severe exacerbations and improved asthma control, and in patients already receiving inhaled corticosteroid, adding formoterol was more effective than doubling the cortiosteroid dose.
Journal ArticleDOI
Asthma as an axon reflex
TL;DR: In asthma, damage to airway epithelium, possibly caused by eosinophil products, exposes C-fibre afferent nerve endings and Stimulation of these endings by inflammatory mediators may result in an axon (local) reflex, which could account for at least some of the pathophysiology of asthma and this concept might lead to new strategies for treatment.